PortfoliosLab logoPortfoliosLab logo
BIVI vs. FBLG
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

BIVI vs. FBLG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioVie Inc. (BIVI) and FibroBiologics, Inc (FBLG). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BIVI vs. FBLG - Yearly Performance Comparison


2026 (YTD)20252024
BIVI
BioVie Inc.
18.97%-94.20%-80.77%
FBLG
FibroBiologics, Inc
-70.43%-88.76%-93.13%

Fundamentals

EPS

BIVI:

-$1.88

FBLG:

-$0.45

Total Revenue (TTM)

BIVI:

$0.00

FBLG:

$0.00

Gross Profit (TTM)

BIVI:

-$172.03K

FBLG:

-$231.00K

EBITDA (TTM)

BIVI:

-$17.44M

FBLG:

-$17.74M

Returns By Period

In the year-to-date period, BIVI achieves a 18.97% return, which is significantly higher than FBLG's -70.43% return.


BIVI

1D
-1.43%
1M
2.99%
YTD
18.97%
6M
-30.65%
1Y
-83.57%
3Y*
-88.05%
5Y*
-76.36%
10Y*
-52.53%

FBLG

1D
0.76%
1M
-84.15%
YTD
-70.43%
6M
-87.29%
1Y
-92.27%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BioVie Inc.

FibroBiologics, Inc

Often compared with FBLG:
FBLG vs. BFRG

Return for Risk

BIVI vs. FBLG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIVI
BIVI Risk / Return Rank: 99
Overall Rank
BIVI Sharpe Ratio Rank: 99
Sharpe Ratio Rank
BIVI Sortino Ratio Rank: 66
Sortino Ratio Rank
BIVI Omega Ratio Rank: 66
Omega Ratio Rank
BIVI Calmar Ratio Rank: 55
Calmar Ratio Rank
BIVI Martin Ratio Rank: 1818
Martin Ratio Rank

FBLG
FBLG Risk / Return Rank: 66
Overall Rank
FBLG Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
FBLG Sortino Ratio Rank: 44
Sortino Ratio Rank
FBLG Omega Ratio Rank: 44
Omega Ratio Rank
FBLG Calmar Ratio Rank: 33
Calmar Ratio Rank
FBLG Martin Ratio Rank: 99
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIVI vs. FBLG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioVie Inc. (BIVI) and FibroBiologics, Inc (FBLG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIVIFBLGDifference

Sharpe ratio

Return per unit of total volatility

-0.78

-0.72

-0.06

Sortino ratio

Return per unit of downside risk

-1.45

-1.70

+0.24

Omega ratio

Gain probability vs. loss probability

0.81

0.78

+0.03

Calmar ratio

Return relative to maximum drawdown

-0.94

-0.97

+0.03

Martin ratio

Return relative to average drawdown

-1.19

-1.46

+0.27

BIVI vs. FBLG - Sharpe Ratio Comparison

The current BIVI Sharpe Ratio is -0.78, which is comparable to the FBLG Sharpe Ratio of -0.72. The chart below compares the historical Sharpe Ratios of BIVI and FBLG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


BIVIFBLGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.78

-0.72

-0.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.58

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

-0.60

+0.37

Correlation

The correlation between BIVI and FBLG is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

BIVI vs. FBLG - Dividend Comparison

Neither BIVI nor FBLG has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BIVI vs. FBLG - Drawdown Comparison

The maximum BIVI drawdown since its inception was -99.98%, roughly equal to the maximum FBLG drawdown of -99.77%. Use the drawdown chart below to compare losses from any high point for BIVI and FBLG.


Loading graphics...

Drawdown Indicators


BIVIFBLGDifference

Max Drawdown

Largest peak-to-trough decline

-99.98%

-99.77%

-0.21%

Max Drawdown (1Y)

Largest decline over 1 year

-91.38%

-95.22%

+3.84%

Max Drawdown (5Y)

Largest decline over 5 years

-99.95%

Max Drawdown (10Y)

Largest decline over 10 years

-99.98%

Current Drawdown

Current decline from peak

-99.98%

-99.77%

-0.21%

Average Drawdown

Average peak-to-trough decline

-77.66%

-89.43%

+11.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

72.26%

63.56%

+8.70%

Volatility

BIVI vs. FBLG - Volatility Comparison

The current volatility for BioVie Inc. (BIVI) is 26.25%, while FibroBiologics, Inc (FBLG) has a volatility of 76.72%. This indicates that BIVI experiences smaller price fluctuations and is considered to be less risky than FBLG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


BIVIFBLGDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.25%

76.72%

-50.47%

Volatility (6M)

Calculated over the trailing 6-month period

51.57%

121.36%

-69.79%

Volatility (1Y)

Calculated over the trailing 1-year period

108.35%

127.77%

-19.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

131.61%

157.18%

-25.57%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

197.90%

157.18%

+40.72%

Financials

BIVI vs. FBLG - Financials Comparison

This section allows you to compare key financial metrics between BioVie Inc. and FibroBiologics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober00
(BIVI) Total Revenue
(FBLG) Total Revenue
Values in USD except per share items